Involvement of PTHrP behind wasting mechanisms in tumour disease was first suggested from rodent cachexia models, where blocking tumor-secreted PTHrP with antibodies alleviated cachexia [14,15] suggesting attenuation of effector mechanisms to prevent tumor-host wasting. The gene discussed is PTHLH; the disease is neoplasm.